rs387907039
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PM1PM2PP3_StrongPP5
The NM_024306.5(FA2H):c.703C>T(p.Arg235Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00000867 in 1,613,916 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_024306.5 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary spastic paraplegia 35Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FA2H | NM_024306.5 | c.703C>T | p.Arg235Cys | missense_variant | Exon 5 of 7 | ENST00000219368.8 | NP_077282.3 | |
FA2H | XM_011523317.4 | c.703C>T | p.Arg235Cys | missense_variant | Exon 5 of 6 | XP_011521619.1 | ||
FA2H | XM_011523319.3 | c.463C>T | p.Arg155Cys | missense_variant | Exon 5 of 7 | XP_011521621.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FA2H | ENST00000219368.8 | c.703C>T | p.Arg235Cys | missense_variant | Exon 5 of 7 | 1 | NM_024306.5 | ENSP00000219368.3 | ||
FA2H | ENST00000569949.1 | c.505C>T | p.Arg169Cys | missense_variant | Exon 5 of 5 | 4 | ENSP00000464576.1 | |||
FA2H | ENST00000567683.5 | n.453C>T | non_coding_transcript_exon_variant | Exon 3 of 5 | 2 | ENSP00000455126.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152204Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251222 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461712Hom.: 0 Cov.: 33 AF XY: 0.00000688 AC XY: 5AN XY: 727148 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152204Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74354 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 35 Pathogenic:3
- -
- -
- -
not provided Pathogenic:1
Published functional studies demonstrate a reduction in 2-hydroxylated ceramide activity (Dick et al., 2010); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 26944241, 33144682, 20104589) -
Intellectual disability Pathogenic:1
- -
not specified Uncertain:1
Variant summary: FA2H c.703C>T (p.Arg235Cys) results in a non-conservative amino acid change located in the Fatty acid hydroxylase domain (IPR006694) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251222 control chromosomes. c.703C>T has been reported in the literature as a homozygous genotype in one individual affected with autosomal recessive form of HSP (SPG35) (example, Dick_2010). These data indicate that the variant may be associated with disease. However, a subsequent study has reported that cerebral iron accumulation is not a major feature of FA2H associated autosomal recessive spastic paraplegia (SPG35) (Marelli_2015). Therefore, these report(s) do not provide unequivocal conclusions about association of the variant with Neurodegeneration with brain iron accumulation. At least one publication reports experimental evidence evaluating an impact on protein function (Dick_2010). The most pronounced variant effect results in >50%-90% of normal levels of hydroxylated ceramides. One clinical diagnostic laboratory (most likely the originator of the reported individual, Dick_2010) has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at